The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas
- 1 October 1987
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 5 (4) , 281-293
- https://doi.org/10.1002/hon.2900050406
Abstract
Autologous bone marrow transplantation (ABMT) following intensive therapy regimes is being used increasingly in relapsed lymphomas. To date no randomised studies have been performed to ascertain the value of this form of therapy. We describe here our experience of ABMT in both Hodgkin's disease and Non‐Hodgkin's Lymphoma and review the situations in which we believe future randomised studies should be based.Keywords
This publication has 23 references indexed in Scilit:
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30)Clinical Radiology, 1987
- Randomised study of MOPP (mustine, Oncovin, procarbazine,prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's diseaseRadiotherapy and Oncology, 1986
- High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- Selection of patients with hodgkin's disease and non-hodgkin's lymphoma for bone marrow transplantationThe International Journal of Cell Cloning, 1986
- ANTI-B1 MONOCLONAL ANTIBODY AND COMPLEMENT TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED B-CELL NON-HODGKIN'S LYMPHOMAThe Lancet, 1984
- Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous MarrowNew England Journal of Medicine, 1984
- ROLE OF MASSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKIN'S MALIGNANT LYMPHOMAThe Lancet, 1984
- The prognostic significance of age in Hodgkin's disease: Examination of 1500 patients (BNLI report no. 23)Clinical Radiology, 1983
- Combination chemotherapy for Stage IV Hodgkin's disease (report no 14)Clinical Radiology, 1981